Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

MPLT

MPLT News

Newswire

14:02

MapLight Therapeutics' 15min chart shows MACD Death Cross and KDJ Death Cross signals.

09:46

MapLight Therapeutics to Report Schizophrenia Trial Results in 2H 2026

09:38

MapLight Therapeutics shares surge 31.26% intraday after $296.5M IPO and progress in Phase 2 CNS trials extend cash runway through 2027.

07:07

MapLight Raises $296.5mln, Funds Through 2027, Trials Expected in H2 2026-27

17:28

MapLight Therapeutics shares surge 29.48% after-hours after Stifel Nicolaus maintains Buy rating and Leerink initiates Outperform.

View More

About MPLT

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More